Cryoablation for renal tumors: Current status

Andre Berger, Kazumi Kamoi, Inderbir S. Gill, Monish Aron

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose of review To review the evolution and current status of cryoablation for renal tumors. Recent findings Cryoablation is the most evaluated probe ablative method for the treatment of small renal masses. It is associated with high efficacy and low morbidity. New data on intermediate and long-term oncological outcomes are now available. Five and 10-year cancer-specific survival are 93 and 81%, respectively. Renal cryoablation is most commonly performed percutaneously or laparoscopically. Recently, single-port laparoscopic and natural orifice transluminal endoscopic surgery approaches have also been employed for renal cryotherapy. Summary With careful patient selection, the intermediate-term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory. Combination with new technologies and further development of imaging techniques can potentially expand the range of indications of the procedure.

Original languageEnglish (US)
Pages (from-to)138-142
Number of pages5
JournalCurrent Opinion in Urology
Volume19
Issue number2
DOIs
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Cryosurgery
Kidney
Neoplasms
Natural Orifice Endoscopic Surgery
Cryotherapy
Patient Selection
Technology
Morbidity

Keywords

  • Cryoablation
  • Cryotherapy
  • Kidney tumor
  • Nephron sparing surgery
  • Renal cell carcinoma
  • Renal mass

ASJC Scopus subject areas

  • Urology

Cite this

Cryoablation for renal tumors : Current status. / Berger, Andre; Kamoi, Kazumi; Gill, Inderbir S.; Aron, Monish.

In: Current Opinion in Urology, Vol. 19, No. 2, 03.2009, p. 138-142.

Research output: Contribution to journalArticle

Berger, A, Kamoi, K, Gill, IS & Aron, M 2009, 'Cryoablation for renal tumors: Current status', Current Opinion in Urology, vol. 19, no. 2, pp. 138-142. https://doi.org/10.1097/MOU.0b013e328323f618
Berger, Andre ; Kamoi, Kazumi ; Gill, Inderbir S. ; Aron, Monish. / Cryoablation for renal tumors : Current status. In: Current Opinion in Urology. 2009 ; Vol. 19, No. 2. pp. 138-142.
@article{2d0646a4aa454ca18107a54b061701c2,
title = "Cryoablation for renal tumors: Current status",
abstract = "Purpose of review To review the evolution and current status of cryoablation for renal tumors. Recent findings Cryoablation is the most evaluated probe ablative method for the treatment of small renal masses. It is associated with high efficacy and low morbidity. New data on intermediate and long-term oncological outcomes are now available. Five and 10-year cancer-specific survival are 93 and 81{\%}, respectively. Renal cryoablation is most commonly performed percutaneously or laparoscopically. Recently, single-port laparoscopic and natural orifice transluminal endoscopic surgery approaches have also been employed for renal cryotherapy. Summary With careful patient selection, the intermediate-term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory. Combination with new technologies and further development of imaging techniques can potentially expand the range of indications of the procedure.",
keywords = "Cryoablation, Cryotherapy, Kidney tumor, Nephron sparing surgery, Renal cell carcinoma, Renal mass",
author = "Andre Berger and Kazumi Kamoi and Gill, {Inderbir S.} and Monish Aron",
year = "2009",
month = "3",
doi = "10.1097/MOU.0b013e328323f618",
language = "English (US)",
volume = "19",
pages = "138--142",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Cryoablation for renal tumors

T2 - Current status

AU - Berger, Andre

AU - Kamoi, Kazumi

AU - Gill, Inderbir S.

AU - Aron, Monish

PY - 2009/3

Y1 - 2009/3

N2 - Purpose of review To review the evolution and current status of cryoablation for renal tumors. Recent findings Cryoablation is the most evaluated probe ablative method for the treatment of small renal masses. It is associated with high efficacy and low morbidity. New data on intermediate and long-term oncological outcomes are now available. Five and 10-year cancer-specific survival are 93 and 81%, respectively. Renal cryoablation is most commonly performed percutaneously or laparoscopically. Recently, single-port laparoscopic and natural orifice transluminal endoscopic surgery approaches have also been employed for renal cryotherapy. Summary With careful patient selection, the intermediate-term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory. Combination with new technologies and further development of imaging techniques can potentially expand the range of indications of the procedure.

AB - Purpose of review To review the evolution and current status of cryoablation for renal tumors. Recent findings Cryoablation is the most evaluated probe ablative method for the treatment of small renal masses. It is associated with high efficacy and low morbidity. New data on intermediate and long-term oncological outcomes are now available. Five and 10-year cancer-specific survival are 93 and 81%, respectively. Renal cryoablation is most commonly performed percutaneously or laparoscopically. Recently, single-port laparoscopic and natural orifice transluminal endoscopic surgery approaches have also been employed for renal cryotherapy. Summary With careful patient selection, the intermediate-term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory. Combination with new technologies and further development of imaging techniques can potentially expand the range of indications of the procedure.

KW - Cryoablation

KW - Cryotherapy

KW - Kidney tumor

KW - Nephron sparing surgery

KW - Renal cell carcinoma

KW - Renal mass

UR - http://www.scopus.com/inward/record.url?scp=61349098828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349098828&partnerID=8YFLogxK

U2 - 10.1097/MOU.0b013e328323f618

DO - 10.1097/MOU.0b013e328323f618

M3 - Article

C2 - 19188767

AN - SCOPUS:61349098828

VL - 19

SP - 138

EP - 142

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 2

ER -